<DOC>
	<DOCNO>NCT02108288</DOCNO>
	<brief_summary>OPC-1085EL ophthalmic solution , carteolol long-acting ophthalmic solution latanoprost ophthalmic solution administer daily 7 day effect blood concentration carteolol latanoprost OPC-1085EL ophthalmic solution formulate combination drug determine .</brief_summary>
	<brief_title>Pharmacokinetic Study OPC-1085EL Ophthalmic Solution Healthy Male Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Carteolol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Subjects consider medically healthy per investigator 's judgment Subjects ocular condition define protocol Subjects intraocular pressure : &lt; 10 â‰¥22 mmHg</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>